Skip to main content
Thursday, 24 October 2024

Medical pioneers and First Nations leaders among Academy’s 31 new Fellows

Medical pioneers and First Nations leaders among Academy’s 31 new Fellows

Indigenous health leaders, an immunisation expert, a drug discoverer and a pioneering genomicist are among the 31 new Fellows elected to join the Australian Academy of Health and Medical Sciences this year.

The Academy welcomed the new Fellows in a ceremony at its Annual Meeting in Adelaide this morning (24 October).

Academy President Professor Louise Baur said new Fellows were elected by their peers through a competitive process, which recognised their significant and continuing contributions to health and medical sciences.

“Our new Fellows have a truly exceptional body of work, with each of them considered international leaders in their respective fields,” she said.

“Our Fellowship represents the breadth and diversity of Australia’s health and medical expertise, allowing us to draw on independent, expert and evidence-based advice to drive change and improve health for all.

“I’m deeply pleased to welcome three First Nations Fellows this year, Professors Dawn Bessarab, Raymond Lovett and James Ward. They have made incredible contributions to the health of Aboriginal and Torres Strait Islander peoples, and to the broader health and medical sciences. First Nations people were the nation’s first scientists, and there is so much that can be learned from their wealth of knowledge and experience.

“This year we also welcome six Fellows who work in allied health, including leaders in clinical exercise physiology, social work, exercise oncology, physiotherapy and fall prevention, preoperative exercise and rehabilitation, and mental health.

“I’m also pleased to welcome two Fellows from industry, drug discoverer Dr Christopher Burns and clinical pharmacologist Adjunct Professor Craig Rayner.”

The 2024 new Academy Fellows are listed below, or click through the gallery to read their citations.

Professor Scott Bell FAHMS, CEO, Translational Research Institute (QLD)
Professor Scott Bell is an internationally recognised respiratory physician and research leader who has enhanced understanding of the mechanisms of infection acquisition and transmission in people with cystic fibrosis.


Professor Dawn Bessarab FAHMS, Director, Centre for Aboriginal Medical and Dental Health, The University of Western Australia (WA) Professor Dawn Bessarab has shown exceptional Indigenous leadership, knowledge, expertise and contribution through research in Indigenous health and social work.


Professor Christopher Blyth FAHMS, Professor of Paediatric Infectious Diseases, The University of Western Australia and Head, Wesfarmers Centre of Vaccines & Infectious Diseases, Kids Research Institute Australia (WA) Professor Christopher Blyth has made substantial contributions to health, informing international immunisation, infection prevention and management policy and practice. Professor Blyth’s research and advocacy has driven changes to immunisation programs globally.


Professor Asha Bowen OAM FAHMS, Paediatric Infectious Diseases Specialist at Perth Children’s Hospital and Head, Healthy Skin and ARF Prevention at The Kids Research Institute Australia Professor Asha Bowen has generated new knowledge to improve skin health, including being first in describing the heavy burden for remote Aboriginal children. Her new research methodologies for remote skin health research are used globally.


Dr Christopher Burns FAHMS, Chief Executive Officer and Managing Director, Amplia Therapeutics Ltd (VIC)
Dr Christopher Burns is an accomplished and highly regarded medicinal chemist and drug discoverer. He has worked in both industry and academia, and is an inventor on 29 patents and co-author of 68 scientific publications.


Professor Patricia Davidson FAHMS, Vice-Chancellor’s Fellow, UNSW Sydney (NSW)
Professor Patricia Davidson is a global leader in health service development and advocacy, focusing on person-centred care delivery and improving cardiovascular health outcomes for at-risk populations.


Professor Kim Delbaere FAHMS, Senior Principal Research Fellow, Neuroscience Research Australia (NSW)
Professor Kim Delbaere has made major contributions to identifying risk factors for falls and sub-optimal ageing. Her vision is for older Australians to understand and navigate better health trajectories through self-management.


Professor Linda Denehy FAHMS, Professor of Physiotherapy, The University of Melbourne (VIC)
Professor Linda Denehy is a physiotherapist and clinician-researcher who has pioneered rehabilitation in the fields of critical care and cancer. Her highly productive research career puts her in the top 0.1% of rehabilitation experts worldwide.


Professor Jane Fisher AO FAHMS, Finkel Professor of Global Health, Monash University (VIC)
Professor Jane Fisher's research on the social and psychological determinants of perinatal mental health problems has informed prevention and early intervention programs in Australia and internationally.


Professor Sharon Goldfeld AM FAHMS, Director, Centre for Community and Child Health, Royal Children’s Hospital, and Director Population Health, Murdoch Children's Research Institute (VIC)
Professor Sharon Goldfeld is an expert in policy, a paediatrician, and a public health clinician-scientist. She leads an innovative program focused on sustainable policy-relevant solutions that can eliminate inequities for Australia’s children.


Professor Justin Gooding FAA FTSE FAHMS, NHMRC Leadership Fellow; Scientia Professor UNSW Sydney (NSW)
Scientia Professor Justin Gooding is an international leader in the field of surface chemistry who has used his expertise to make pioneering advances in the areas of biosensing, biomaterials and cell biology.


Professor Daniel Green FAHMS, Professor, School of Human Sciences, The University of Western Australia (WA)
Professor Daniel Green’s research provides a compelling evidence base for disease prevention by quantifying the mechanisms and benefits of novel interventions to prevent and manage cardiovascular diseases.


Professor Elizabeth Hartland AM FAHMS, Director and CEO, Hudson Institute of Medical Research (VIC)
Professor Elizabeth Hartland's internationally recognised research informs fundamental knowledge of host-pathogen interactions and the development of anti-infective and immune-enhancing therapies that target the infection process.


Professor Vanessa Hayes FAHMS, Petre Chair of Prostate Cancer Research, The University of Sydney (NSW)
Professor Vanessa Hayes is a genomicist and pioneer in mapping human diversity and global prostate tumour complexity and disparities, with a focus on underserved populations.


Professor Livia Hool FAHMS, Wesfarmers UWA-VCCRI Chair in Cardiovascular Research, The University of Western Australia (WA)
Professor Livia Hool is an international leader in the study of excitation and contraction of the heart. Her work aims to improve the lives of patients with inherited heart disease.


Professor Paul James FAHMS, Director, Parkville Familial Cancer Clinic, The Royal Melbourne Hospital (VIC)
Professor Paul James is a skilled clinician-scientist who, through his initiatives and international collaborations, has brought about significant changes in clinical practice and policy in heritable cancer investigation, diagnosis and management.


Professor Raymond Lovett FAHMS, Associate Director, Culture and Wellbeing Research, Yardhura Walani Centre, Australian National University (ACT)
Professor Raymond Lovett is one of Australia’s most influential and respected Indigenous (Ngiyampaa/Wongaibon) epidemiologists. He has led large-scale research programs that translate to tangible and enduring benefits for Aboriginal and Torres Strait Islander peoples.


Professor Deborah Lupton FASSA FAHMS, SHARP Professor and Vitalities Lab Leader, UNSW Sydney (NSW)
Professor Deborah Lupton’s research is interdisciplinary, spanning public health, medical sociology, digital health, and communication studies. She is one of the top-most cited social researchers worldwide.


Professor Stuart MacGregor FAHMS, Group Leader, QIMR Berghofer Medical Research Institute (QLD)
Professor Stuart MacGregor is a world authority on the conduct and analysis of genetic association studies. He has led studies which have mapped hundreds of genes for diseases ranging from skin cancer to eye disease.


Professor Raina MacIntyre FAHMS, Head, Biosecurity Program, UNSW Sydney (NSW)
Professor Raina MacIntyre has contributed a seminal body of research on vaccinology, face masks, respirators and transmission of respiratory pathogens, as well as epidemic response and emerging infectious diseases - including COVID-19.


Professor Robert Newton FAHMS, Professor of Exercise Medicine, Edith Cowan University (WA)
Professor Robert Newton is an exercise oncology expert whose work focuses on exercise medicine as neoadjuvant, adjuvant and rehabilitative cancer therapy to reduce side-effects and enhance effectiveness of surgery, chemotherapy and radiation therapy.


Professor Andreas Obermair FAHMS, Senior Medical Officer; Director of Research, QLD Centre for Gynaecological Cancer at The University of Queensland, Royal Brisbane and Women's Hospital (QLD)
Professor Andreas Obermair is a gynaecologic oncologist, surgical teacher, researcher and consumer advocate. His research influences clinical management of patients with cervical, endometrial and vulvar cancer.


Deakin Distinguished Professor Anna Peeters AM FAHMS, Director, Institute for Health Transformation, Deakin University (VIC)
Professor Anna Peeters is a world leader in public health research focused on population nutrition and obesity prevention. Her work builds evidence for more effective and equitable prevention and healthcare through capacity building, partnerships, and impact.


Professor Sarath Ranganathan FAHMS, Melbourne Medical School Head of School, The University of Melbourne (VIC)
Professor Sarath Ranganathan is an international expert in paediatric lung disease, and his research has led to a paradigm shift in the understanding and treatment of cystic fibrosis. His research has shaped changes in clinical practice globally.


Adjunct Professor Craig Rayner FAHMS FTSE, pharmaceutical development expert, Moderna (VIC)
Adjunct Professor Craig Rayner has excelled across research and development sectors as a prominent medicine developer against global health threats. As an experienced executive, he has built companies to multibillion dollar value and is committed to improving Australian R&D.


Professor Julie Simpson FAHMS, Head of Biostatistics Unit, Melbourne School of Population and Global Health, and Director, Methods and Implementation Support for Clinical and Health (MISCH) Research Hub, The University of Melbourne (VIC)
Professor Julie Simpson is recognised internationally for her leadership in biostatistics and contributions to pioneering work on novel treatments and disease prevention, with a focus on malaria.


Cojoint Professor Stephen Tong FAHMS, Professor of Obstetrics and Gynaecology, The University of Melbourne, (VIC)
Professor Stephen Tong is a leading global translational researcher in obstetrics. He is developing new diagnostics and therapeutics to tackle life-endangering pregnancy conditions – preeclampsia, ectopic pregnancy and stillbirth.


Professor James Ward FAHMS, Director, UQ Poche Centre for Indigenous Health, The University of Queensland (QLD)
Professor James Ward is a Pitjantjatjara and Narungga man, and a national leader in Indigenous health. He is an infectious diseases epidemiologist, and his research has been fundamental in shaping policy, clinical guidelines, and resourcing in Indigenous health.


Professor Anthony Weiss AM FTSE FAHMS, McCaughey Chair in Biochemistry, The University of Sydney (NSW)
Professor Anthony Weiss is an outstanding multifaceted biomedical innovator, mentor and leader. He is a world leader in molecular studies of human tropoelastin and its assembly to make three-dimensional elastin protein biomaterials.


Professor James Whisstock FAHMS, Deputy Dean Research, Faculty of Medicine Nursing and Health Sciences, Monash University (VIC) Professor James Whisstock’s discoveries include elucidating the mechanism of function of perforin-like proteins and using his discoveries to develop new immunotherapeutics.


Professor Steve Wilton AO FAHMS, Deputy Director, Centre for Molecular Medicine and Innovative Therapeutics, Murdoch University (WA)
Professor Steve Wilton was an early pioneer in the use of antisense oligomers to treat Duchenne muscular dystrophy. His team is currently exploring treatments for scores of diseases, aiming to develop new therapeutics for many inherited and acquired conditions.





  • Professor Scott Bell FAHMS, Translational Research Institute
  • Professor Dawn Bessarab FAHMS, The University of Western Australia
  • Professor Christopher Blyth FAHMS, The University of Western Australia/The Kids Research Institute Australia
  • Professor Asha Bowen OAM FAHMS, Perth Children’s Hospital/The Kids Research Institute Australia
  • Dr Christopher Burns FAHMS, Amplia Therapeutics Ltd
  • Professor Patricia Davidson FAHMS, UNSW Sydney
  • Professor Kim Delbaere FAHMS, Neuroscience Research Australia
  • Professor Linda Denehy FAHMS, The University of Melbourne
  • Professor Jane Fisher AO FAHMS, Monash University
  • Professor Sharon Goldfeld AM FAHMS, Royal Children’s Hospital/Murdoch Children’s Research Institute
  • Professor Justin Gooding FAA FTSE FAHMS, UNSW Sydney
  • Professor Daniel Green FAHMS, The University of Western Australia
  • Professor Elizabeth Hartland AM FAHMS, Hudson Institute of Medical Research
  • Professor Vanessa Hayes FAHMS, The University of Sydney
  • Professor Livia Hool FAHMS, The University of Western Australia
  • Professor Paul James FAHMS, The Royal Melbourne Hospital
  • Professor Raymond Lovett FAHMS, Australian National University
  • Professor Deborah Lupton FASSA FAHMS, UNSW Sydney
  • Professor Stuart MacGregor FAHMS, QIMR Berghofer Medical Research Institute
  • Professor Raina MacIntyre FAHMS, UNSW Sydney
  • Professor Robert Newton FAHMS, Edith Cowan University
  • Professor Andreas Obermair FAHMS, Royal Brisbane and Women’s Hospital/The University of Queensland
  • Deakin Distinguished Professor Anna Peeters AM FAHMS, Deakin University
  • Professor Sarath Ranganathan FAHMS, The University of Melbourne
  • Adjunct Professor Craig Rayner FAHMS FTSE, Moderna
  • Professor Julie Simpson FAHMS, The University of Melbourne
  • Cojoint Professor Stephen Tong FAHMS, The University of Melbourne
  • Professor James Ward FAHMS, The University of Queensland
  • Professor Anthony Weiss AM FTSE FAHMS, The University of Sydney
  • Professor James Whisstock FAHMS, Monash University
  • Professor Steve Wilton AO FAHMS, Murdoch University

Media: AAHMS Head of Media and Communication Katie Rowney, [email protected] or P: 07 3102 7212 M: +61 (0) 419 787 551

Hi-res images of all new Fellows are available on request.

AAHMS

Related Publications

AAHMS Fellows recognised in King’s Birthday Honours
10 June 2026 News

AAHMS Fellows recognised in King’s Birthday Honours

Academy welcomes Senate report on microplastics
29 May 2026 Media Release, News

Academy welcomes Senate report on microplastics

Academy welcomes HMR Strategy as major step
23 May 2026 Media Release, News

Academy welcomes HMR Strategy as major step

Secret Link